Results of implementation of viral hepatitis B elimination program in the North-West Russia
Open Access
- 1 September 2021
- journal article
- research article
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 11 (5) , 875-886
Abstract
Introduction. Vaccination contributed to reduce the incidence of acute hepatitis B in the territories of the North-West Russia. The urgency of this problem remains due to the high incidence of chronic hepatitis B. This accounted for the need to develop a hepatitis B elimination program in the district discussed that was approved in 2013 by the head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. Objective is to characterize the results of the program for the elimination of acute hepatitis B virus implemented in the North-Western Federal District. Materials and methods. The 2010–2020 incidence rate of acute and chronic hepatitis B virus (HBV) infection in the regions of the North-West Russia was carried out. To determine HBV genotypes and subgenotypes, 160 blood plasma samples from patients with acute hepatitis B were studied using molecular genetic methods (PCR, sequencing). The prevalence of latent hepatitis B in various population groups was assessed. The 2016–2020 hepatitis B vaccination coverage and relevant serological monitoring in adults was carried out. Results. While implementing the program, it was found that the incidence rate of acute hepatitis B in the district decreased by 4.5-fold, revealing in 2020 no cases of the disease in 5 regions, with incidence rate in the 6 subfederal units being lower than 1.0 per 100,000 population. Moreover, the incidence rate for chronic hepatitis B decreased by 2.6 times. The 2020 vaccination coverage of children under 17 and adults in all territories comprised more than 95% and 90%, respectively. In addition, it was shown the circulation of genotypes D and A of hepatitis B virus is dominated by genotype D (91.8%), subgenotype D2 (47.8%). The prevalence of latent hepatitis B among migrants was 6.5%, pregnant women — 4.9%, hemodialysis patients — 1.7%. Conclusion. Implementation of the program on elimination of acute viral hepatitis B in the territory of the North-West Russia contributed to raise in the vaccination coverage in adult population and lowered incidence rate of acute and chronic HBV infection.Keywords
This publication has 16 references indexed in Scilit:
- Analysis of medical and social factors affecting the formation and course of co-infection HIV, tuberculosis and viral hepatitisRussian Journal of Infection and Immunity, 2020
- Update on global epidemiology of viral hepatitis and preventive strategiesWorld Journal of Clinical Cases, 2018
- Chronic hepatitis B virus infectionThe Lancet, 2018
- Virological Basis for the Cure of Chronic Hepatitis BACS Infectious Diseases, 2018
- Time-series analysis of tuberculosis from 2005 to 2017 in ChinaEpidemiology and Infection, 2018
- Viral hepatitis and liver cancerPhilosophical Transactions of the Royal Society B: Biological Sciences, 2017
- Requirements for global elimination of hepatitis B: a modelling studyThe Lancet Infectious Diseases, 2016
- Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on DiseaseClinics in Liver Disease, 2016
- Immunological effectiveness of mass vaccine prophylaxis against hepatitis B within the framework of the National Priority Project "Health" in some regions of the Russian FederationEpidemiology and Infectious Diseases, 2015
- The Potential of Digital Microscopy in Breast PathologyPathology and Oncology Research, 2008